The global market is estimated to reach $2.0 billion by 2018 at a CAGR of more than 20% between 2013 and 2018.

Dallas, TX -- (ReleaseWire) -- 04/03/2014 --The “Biosimilars Market Product [Recombinant Non-Glycosylated Proteins (Insulin, Filgrastim, Somatropin), Glycosylated (Monoclonal Antibodies, Erythropoietin), Peptides (Glucagon, Calcitonin)] & Application (Oncology, Blood Disorders) - Global Forecast to 2018”, provides a detailed overview of the major drivers,restraints, challenges, opportunities, current market trends, and strategies impacting the global biosimilars market along with the estimates and forecasts of the revenue and share analysis.

Browse 80 market data tables and 80 figures spread through 320 pages and in-depth TOC on “Biosimilars Market”.

Early buyers will receive 10% customization on this report.

Do Inquiry Before Buying@ http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=40

Across the world, various factors have contributed to the rise in demand for biopharmaceutical products such as biologics and biosimilars. These include the rising budgetary pressures to reduce healthcare expenditures, the growing demand for cost-effective alternatives, the growing burden of chronic diseases, and the increase in the aging population in selected geographies. Biosimilars are similar versions of their corresponding patented biologic drugs. Biosimilars should ideally be similar to their reference drugs with regards to quality, safety, and efficacy. The global biosimilars market is estimated to be $783 million in 2013 and will grow at a CAGR of 20.1%by 2018.

This report studies and analyzes the biosimilars market byproduct, application, and service. By product, the global biosimilars market is segmented into recombinant non-glycosylated proteins, recombinant glycosylated proteins, and recombinant peptides. The recombinant non-glycosylated proteins market is further classified into insulin, granulocyte colony-stimulating factor (G-CSF), interferons, and human growth hormone; whereas the recombinant glycosylated proteins market is further broken down into erythropoietin, monoclonal antibodies, and follitropin. The recombinant peptide segment considers glucagon and calcitonin.

By application, the biosimilars market is segmented into oncology, blood disorders, growth hormonal deficiency, chronic and autoimmune disorders, and others (female infertility, hypoglycemia, myocardial infarction, postmenopausal osteoporosis, and chronic kidney failure).

The global market is highly consolidated with the top three players, namely, Sandoz (Germany), Hospira (U.S.), and Teva (Israel) occupying 90% of the market share. Other key players include Dr. Reddy’s Laboratories (India), Biocon Ltd. (India), Mylan (U.S.), Biopartners (Switzerland), Amgen (U.S.), and Intas Biopharmaceutical Ltd. (India).

Browse Related Reports:
Biomarkers Market - ([Discovery Technologies - Proteomics, Genomics, Imaging, Bioinformatics], Validation Services, Applications [drug development, personalized medicine], Diseases [Oncology, Cardiology, Neurology]) - Global Trends & Forecasts (2013 – 2018)
http://www.marketsandmarkets.com/Market-Reports/biomarkers-advanced-technologies-and-global-market-43.html

Global Biobank (Biospecimen/ Biorepository/Biopreservation) Market for Equipment and Media - Trends and Forecast to 2017
http://www.marketsandmarkets.com/Market-Reports/biopreservation-media-storage-equipment-market-842.html

About MarketsandMarkets
MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world.

MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services. MarketsandMarkets covers thirteen industry verticals; including advanced materials, automotive and transportation, banking and financial services, biotechnology, chemicals, consumer goods, telecommunications and IT, energy and power, food and beverages, industrial automation, healthcare IT, medical devices, pharmaceuticals, semiconductor and electronics, aerospace & defense.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

Contact:
Mr. Rohan
North - Dominion Plaza
17304 Preston Road
Suite 800, Dallas, TX 75252
Tel: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit MarketsandMarkets Blog @ http://mnmblog.org/market-research/healthcare/biotechnology
Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets